Hamedani AG - Search Results

1

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

Nelson HS, Busse WW, deBoisblanc BP, Berger WE, Noonan MJ, Webb DR, Wolford JP, Mahajan PS, Hamedani AG, Shah T, Harding SM. Nelson HS, et al. Among authors: hamedani ag. J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):267-75. doi: 10.1016/s0091-6749(99)70501-4. J Allergy Clin Immunol. 1999. PMID: 9949318 Clinical Trial.

2

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.

Li JT, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG, Herje NE, Hamedani A, Harding SM, Shah T. Li JT, et al. J Allergy Clin Immunol. 1999 Jun;103(6):1062-8. doi: 10.1016/s0091-6749(99)70180-6. J Allergy Clin Immunol. 1999. PMID: 10359887 Clinical Trial.

3

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.

Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW. Peden DB, et al. Among authors: hamedani ag. J Allergy Clin Immunol. 1998 Jul;102(1):32-8. doi: 10.1016/s0091-6749(98)70052-1. J Allergy Clin Immunol. 1998. PMID: 9679845 Clinical Trial.

4

Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.

Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM. Galant SP, et al. Among authors: hamedani ag. Ann Allergy Asthma Immunol. 1999 Mar;82(3):273-80. doi: 10.1016/S1081-1206(10)62608-7. Ann Allergy Asthma Immunol. 1999. PMID: 10094218 Clinical Trial.

5

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.

Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A. Pearlman DS, et al. Among authors: hamedani ag. Ann Allergy Asthma Immunol. 1997 Apr;78(4):356-62. doi: 10.1016/S1081-1206(10)63196-1. Ann Allergy Asthma Immunol. 1997. PMID: 9109702 Clinical Trial.

6

A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.

Xu JH, Lu QJ, Huang JH, Hao F, Sun QN, Fang H, Gu J, Dong XQ, Zheng J, Luo D, Li FQ, Wang G, Gu H, Tian HQ, Yang HL, Xi LY, Li M, Zheng M, Wu Y, Tu YT, He YL, Zhao G, Sheng WX, Li J, Hamedani AG. Xu JH, et al. Among authors: hamedani ag. J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1176-82. doi: 10.1111/jdv.13622. Epub 2016 Apr 13. J Eur Acad Dermatol Venereol. 2016. PMID: 27075705 Clinical Trial.

7

A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.

Fowler JF, Graff O, Hamedani AG. Fowler JF, et al. Among authors: hamedani ag. J Drugs Dermatol. 2014 Oct;13(10):1198-204. J Drugs Dermatol. 2014. PMID: 25607554 Clinical Trial.

8

Use of Longitudinal Dose-Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE).

Schmith GD, Singh R, Gomeni R, Graff O, Hamedani AG, Troughton JS, Learned SM. Schmith GD, et al. Among authors: hamedani ag. CPT Pharmacometrics Syst Pharmacol. 2015 Apr;4(4):255-62. doi: 10.1002/psp4.24. Epub 2015 Apr 17. CPT Pharmacometrics Syst Pharmacol. 2015. PMID: 26225249 Free PMC article.

9

Call me Dr Ishmael: trends in electronic health record notes available at emergency department visits and admissions.

Patterson BW, Hekman DJ, Liao FJ, Hamedani AG, Shah MN, Afshar M. Patterson BW, et al. Among authors: hamedani ag. JAMIA Open. 2024 May 22;7(2):ooae039. doi: 10.1093/jamiaopen/ooae039. eCollection 2024 Jul. JAMIA Open. 2024. PMID: 38779571 Free PMC article.

10

Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease.

Safarpour D, Stover N, Shprecher DR, Hamedani AG, Pfeiffer RF, Parkman HP, Quigley EM, Cloud LJ; Other Non-motor Features Working Group of the Parkinson Study Group. Safarpour D, et al. Among authors: hamedani ag. Parkinsonism Relat Disord. 2024 May 3:106982. doi: 10.1016/j.parkreldis.2024.106982. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 38729797 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page